Page last updated: 2024-08-25

s20098 and Aura

s20098 has been researched along with Aura in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agarwal, NB; Azim, MS; Vohora, D1
Bhutada, PS; Patel, FR; Vimala, PV1
Bäuml, J; Förstl, H; Froböse, T; Schreiner, R; Slawik, H; Veselý, Z; Wiegand, M1

Other Studies

3 other study(ies) available for s20098 and Aura

ArticleYear
Effects of agomelatine on pentylenetetrazole-induced kindling, kindling-associated oxidative stress, and behavioral despair in mice and modulation of its actions by luzindole and 1-(m-chlorophenyl) piperazine.
    Epilepsy & behavior : E&B, 2017, Volume: 72

    Topics: Acetamides; Animals; Anticonvulsants; Antioxidants; Depression; Drug Therapy, Combination; Epilepsy; Hippocampus; Hypnotics and Sedatives; Kindling, Neurologic; Male; Mice; Oxidative Stress; Pentylenetetrazole; Seizures; Treatment Outcome; Tryptamines

2017
Therapeutic potential of agomelatine in epilepsy and epileptic complications.
    Medical hypotheses, 2014, Volume: 82, Issue:1

    Topics: Acetamides; Antidepressive Agents; Cell Survival; Circadian Rhythm; Drug Discovery; Epilepsy; Hippocampus; Humans; Melatonin; Models, Biological; Neurogenesis; Receptors, Melatonin; Receptors, Serotonin

2014
Agomelatine improves sleep in a patient with fatal familial insomnia.
    Pharmacopsychiatry, 2012, Volume: 45, Issue:1

    Topics: Acetamides; Adult; Epilepsy; Fatal Outcome; Female; Humans; Hypnotics and Sedatives; Insomnia, Fatal Familial; Severity of Illness Index; Sleep Stages; Treatment Outcome

2012